519 672 2121
Close mobile menu

Xarelto (rivaroxaban) is an anti-coagulant (blood thinner medication) manufactured by Bayer and approved for use in Canada. Xarelto is prescribed to treat or prevent conditions such as deep vein thrombosis, pulmonary embolism, as well as atrial fibrillation and sometimes following certain surgeries to prevent strokes that can occur as a result of blood clots. Siskinds is currently pursuing claims on behalf of those harmed by Xarelto.

Xarelto use tied to serious health problems

Use of Xarelto has been linked to uncontrollable bleeding and hemorrhaging causing serious injuries and, in comes cases, death.

Suffering from taking Xarelto?

If you or someone you know has suffered injuries or complications as a result of bleeding events associated with taking Xarelto, Siskinds may be able to help.

Contact us for more information regarding the case against Xarelto or to receive a free consultation by completing the form below.

Developments

Siskinds has commenced class actions in several provinces in order to represent a class of Canadian individuals and their families who suffered injuries and complications as a result of adverse events associated with Xarelto, specifically uncontrollable bleeding and hemorrhaging.

National class action

On December 16, 2015, Siskinds LLP filed a proposed national Xarelto class action in Saskatchewan. The class action was held on June 23, 2016, pending judgment on another proposed national class action relating to Xarelto in Saskatchewan. 

Québec Xarelto class action

On May 7, 2015, Siskinds, Desmeules, the Quebec firm affiliated with Siskinds has filed a similar Xarelto class action in Quebec. The class action was held on December 7, 2016 pending judgment on the authorization of another class action relating to Xarelto in Quebec.

FAQs

Do I have to pay anything to participate in the Xarelto class action?

Class action lawyers are usually paid on a contingency basis. This means that class action legal counsel are only paid if successful. Class counsel are paid a percentage of any settlement or court award. Class counsel fees are subject to court approval.

Who is affected by the Xarelto class action?

You are affected by the class action and are a “class member” if you were prescribed Xarelto blood thinner medication and suffered complications, including an adverse hemorrhaging (bleeding) event.

You might also be affected by the class action against Xarelto if you are a family member of the “class member” (i.e., you are the parent, sibling, etc. of the person who was prescribed Xarelto and suffered adverse events).

What should I do to protect my rights?

To protect your rights, you should:

  • Keep a record of medical expenses incurred as a result of taking Xarelto—appointments not covered by your provincial health care provider, prescriptions, medical devices, etc.
  • Keep a record of all medical treatments, including the names and contact information of the health care provider (doctor, surgeon, physiotherapist etc.).
  • If possible, keep a journal of symptoms from the medication and note down any times when you are unable to attend work or school as a result of your symptoms.

If you have not done so already, contact Siskinds in order that we can contact your health care providers to obtain relevant medical and pharmacy records. As time passes, it can be more difficult to collect this information. All personal information provided to Siskinds regarding any injuries/symptoms you may have suffered will be kept private and confidential.

How family members can support class members

If you are a family member of the “class member”, you should keep a record of:

  • Any expenses reasonably incurred for the benefit of the class member.
  • Travel expenses incurred in visiting the class member during his or her treatment or recovery.
  • Any services provided for the class member as a result of the injury (i.e., nursing, housekeeping).
  • If the class member is deceased, any funeral expenses reasonably incurred.

I still have a question. Who should I contact?

For answers to common questions about class actions in Canada, such as timelines, eligibility, and settlement information, please visit our Class Action Lawsuit FAQ page.

If you have a question, about the Xarelto case proceedings please complete the form below or call 1.800.461.6166.

Documents

Quebec proceedings

Order staying the proceedings - Quebec Superior Court - December 7, 2016 (in french only)

Application for authorization to institute a class action - May 7, 2o15 (in french only)

Siskinds has commenced class actions in several provinces in order to represent a class of Canadian individuals and their families who suffered injuries and complications as a result of adverse events associated with Xarelto, specifically uncontrollable bleeding and hemorrhaging.

National class action

On December 16, 2015, Siskinds LLP filed a proposed national Xarelto class action in Saskatchewan. The class action was held on June 23, 2016, pending judgment on another proposed national class action relating to Xarelto in Saskatchewan. 

Québec Xarelto class action

On May 7, 2015, Siskinds, Desmeules, the Quebec firm affiliated with Siskinds has filed a similar Xarelto class action in Quebec. The class action was held on December 7, 2016 pending judgment on the authorization of another class action relating to Xarelto in Quebec.

Do I have to pay anything to participate in the Xarelto class action?

Class action lawyers are usually paid on a contingency basis. This means that class action legal counsel are only paid if successful. Class counsel are paid a percentage of any settlement or court award. Class counsel fees are subject to court approval.

Who is affected by the Xarelto class action?

You are affected by the class action and are a “class member” if you were prescribed Xarelto blood thinner medication and suffered complications, including an adverse hemorrhaging (bleeding) event.

You might also be affected by the class action against Xarelto if you are a family member of the “class member” (i.e., you are the parent, sibling, etc. of the person who was prescribed Xarelto and suffered adverse events).

What should I do to protect my rights?

To protect your rights, you should:

  • Keep a record of medical expenses incurred as a result of taking Xarelto—appointments not covered by your provincial health care provider, prescriptions, medical devices, etc.
  • Keep a record of all medical treatments, including the names and contact information of the health care provider (doctor, surgeon, physiotherapist etc.).
  • If possible, keep a journal of symptoms from the medication and note down any times when you are unable to attend work or school as a result of your symptoms.

If you have not done so already, contact Siskinds in order that we can contact your health care providers to obtain relevant medical and pharmacy records. As time passes, it can be more difficult to collect this information. All personal information provided to Siskinds regarding any injuries/symptoms you may have suffered will be kept private and confidential.

How family members can support class members

If you are a family member of the “class member”, you should keep a record of:

  • Any expenses reasonably incurred for the benefit of the class member.
  • Travel expenses incurred in visiting the class member during his or her treatment or recovery.
  • Any services provided for the class member as a result of the injury (i.e., nursing, housekeeping).
  • If the class member is deceased, any funeral expenses reasonably incurred.

I still have a question. Who should I contact?

For answers to common questions about class actions in Canada, such as timelines, eligibility, and settlement information, please visit our Class Action Lawsuit FAQ page.

If you have a question, about the Xarelto case proceedings please complete the form below or call 1.800.461.6166.

Quebec proceedings

Order staying the proceedings - Quebec Superior Court - December 7, 2016 (in french only)

Application for authorization to institute a class action - May 7, 2o15 (in french only)

Contact Us